Bouba, Yagai
 Distribuzione geografica
Continente #
AS - Asia 1.068
NA - Nord America 644
SA - Sud America 270
EU - Europa 233
AF - Africa 117
Continente sconosciuto - Info sul continente non disponibili 65
OC - Oceania 1
Totale 2.398
Nazione #
US - Stati Uniti d'America 581
SG - Singapore 339
BD - Bangladesh 237
BR - Brasile 202
CN - Cina 172
IT - Italia 167
HK - Hong Kong 110
VN - Vietnam 58
CD - Congo 38
CA - Canada 27
CM - Camerun 26
IN - India 26
AR - Argentina 24
MX - Messico 24
ID - Indonesia 16
MY - Malesia 15
IQ - Iraq 14
FI - Finlandia 12
PK - Pakistan 11
TR - Turchia 11
CO - Colombia 10
EC - Ecuador 9
ZA - Sudafrica 9
MA - Marocco 8
PY - Paraguay 8
SA - Arabia Saudita 8
UA - Ucraina 8
FR - Francia 7
UZ - Uzbekistan 7
PH - Filippine 6
TN - Tunisia 6
VE - Venezuela 6
GB - Regno Unito 5
NP - Nepal 5
DE - Germania 4
EG - Egitto 4
ES - Italia 4
JM - Giamaica 4
NG - Nigeria 4
RU - Federazione Russa 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
CH - Svizzera 3
CL - Cile 3
ET - Etiopia 3
OM - Oman 3
PL - Polonia 3
PS - Palestinian Territory 3
AZ - Azerbaigian 2
BH - Bahrain 2
CR - Costa Rica 2
DZ - Algeria 2
GE - Georgia 2
HU - Ungheria 2
JP - Giappone 2
KE - Kenya 2
LB - Libano 2
MN - Mongolia 2
MW - Malawi 2
MZ - Mozambico 2
NO - Norvegia 2
PE - Perù 2
PR - Porto Rico 2
AU - Australia 1
BF - Burkina Faso 1
BO - Bolivia 1
BW - Botswana 1
BZ - Belize 1
CG - Congo 1
CU - Cuba 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GF - Guiana Francese 1
GR - Grecia 1
IL - Israele 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LY - Libia 1
MK - Macedonia 1
MU - Mauritius 1
NE - Niger 1
NL - Olanda 1
PT - Portogallo 1
QA - Qatar 1
RE - Reunion 1
RO - Romania 1
RS - Serbia 1
SE - Svezia 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TD - Ciad 1
TH - Thailandia 1
Totale 2.330
Città #
San Jose 271
Singapore 181
Hong Kong 109
Beijing 84
Ashburn 75
Rome 67
Kinshasa 38
Santa Clara 32
New York 29
Ho Chi Minh City 28
Los Angeles 24
Hanoi 16
Mexico City 16
Milan 16
Yaoundé 16
São Paulo 15
Buffalo 14
Turku 12
Baghdad 7
Brasília 7
Kuala Lumpur 7
Belo Horizonte 6
Dhaka 6
Goiânia 6
Naples 6
Rio de Janeiro 6
Tashkent 6
Toronto 6
Asunción 5
Dallas 5
Florence 5
Kingston 5
Lahore 5
Porto Alegre 5
Campinas 4
Genoa 4
Jakarta 4
Montreal 4
Riyadh 4
Abuja 3
Agadir 3
Bari 3
Cairo 3
Calgary 3
Catania 3
Charlotte 3
Curitiba 3
Dietikon 3
Figino 3
Fortaleza 3
Haiphong 3
Hampton 3
Istanbul 3
Jaboatão dos Guararapes 3
Medellín 3
Montevideo 3
Muscat 3
Pasadena 3
Quito 3
Sete Lagoas 3
The Dalles 3
Verona 3
Addis Ababa 2
Americana 2
Antakya 2
Baku 2
Betim 2
Blantyre 2
Brescia 2
Buenos Aires 2
Cachoeiro de Itapemirim 2
Cagliari 2
Camaçari 2
Caxias do Sul 2
Chennai 2
Chicago 2
Cleveland 2
Dammam 2
Denver 2
Durban 2
Franca 2
Guayaquil 2
Hangzhou 2
Jequié 2
Johannesburg 2
Joinville 2
Kathmandu 2
Kolkata 2
Lima 2
Luziânia 2
Madison 2
Magetan 2
Maputo 2
Medan 2
Mirassol 2
Mérida 2
Nairobi 2
Najaf 2
Ninh Bình 2
Ottawa 2
Totale 1.301
Nome #
HIV-1 cross-resistance to second-generation non-nucleoside reverse transcriptase inhibitors among individuals failing antiretroviral therapy in Cameroon: implications for the use of long-acting treatment regimens in low- and middle-income countries 144
Identification of gp120 polymorphisms in HIV-1 B subtype potentially associated with resistance to fostemsavir 116
Confirmed virological failure following enhanced adherence counseling among virally unsuppressed children and adolescents on dolutegravir-based versus other regimens: Evidence from a cohort analysis in Cameroon 85
Variability of High-Risk Human Papillomavirus and Associated Factors among Women in Sub-Saharan Africa: A Systematic Review and Meta-Analysis 77
Usability of three finger-stick whole blood HIV self-testing kits among men who have sex with men and female sex workers in Yaounde and Douala, Cameroon 75
Virological response and resistance profile in highly treatment-experienced HIV-1-infected patients switching to dolutegravir plus boosted darunavir in clinical practice 66
Determinants of Immunovirological Response among Children and Adolescents Living with HIV-1 in the Central Region of Cameroon 66
HIV MDR is still a relevant issue despite its dramatic drop over the years 66
Evaluation of HIV-1 capsid genetic variability and lenacapavir (GS-6207) drug resistance-associated mutations according to viral clades among drug-naive individuals 59
HIV susceptibility to second-generation integrase strand transfer inhibitors among people with multidrug resistance: a systematic review and meta-analysis protocol 58
The Determinants of the Low COVID-19 Transmission and Mortality Rates in Africa: a Cross-Country Analysis 57
Viral dynamics and factors associated with duration of COVID-19 positivity: evidence from the first-three epidemiological waves in Cameroon 57
Evaluating the effectiveness of oral HIV self testing according to distribution models in Cameroon 55
Evaluation of Viral Suppression in Paediatric Populations: Implications for the Transition to Dolutegravir-Based Regimens in Cameroon: The CIPHER-ADOLA Study 55
The mother-to-child transmission of HIV-1 and profile of viral reservoirs in pediatric population: A systematic review with meta-analysis of the Cameroonian studies 55
Baseline integrase drug resistance mutations and conserved regions across HIV-1 clades in Cameroon: implications for transition to dolutegravir in resource-limited settings 52
Genotypic HIV-1 tropism determination might help to identify people with exhausted treatment options and advanced disease 51
Characterisation of HIV-1 reservoirs in paediatric populations: protocol for a systematic review and meta-analysis 47
Detection of Gag C-terminal mutations among HIV-1 non-B subtypes in a subset of Cameroonian patients 45
Evaluation of virological response and resistance profile in HIV-1 infected patients starting a first-line integrase inhibitor-based regimen in clinical settings 45
HIV-1 drug resistance in children and implications for pediatric treatment strategies: A systematic review and meta-analysis 42
Tenofovir and Doravirine Are Potential Reverse-Transcriptase Analogs in Combination with the New Reverse-Transcriptase Translocation Inhibitor (Islatravir) Among Treatment-Experienced Patients in Cameroon: Designing Future Treatment Strategies for Low- and Middle-Income Countries 42
Early versus delayed antiretroviral therapy based on genotypic resistance test: Results from a large retrospective cohort study 41
Anti-toxoplasmic immunoglobulin G quantitation correlates with immunovirological parameters of HIV-infected cameroonians 40
Viral suppression in the era of transition to dolutegravir-based therapy in Cameroon: Children at high risk of virological failure due to the lowly transition in pediatrics 39
High genotypic diversity of human papillomavirus among women in Cameroon: implications for vaccine effectiveness 38
Characterization of HIV-1 Reservoirs in Children and Adolescents: A Systematic Review and Meta-Analysis Toward Pediatric HIV Cure 37
The 2019 cameroon university games: Prevention strategies for musculoskeletal injuries 37
Factors Associated with Low-Level Viremia in People Living with HIV in the Italian Antiviral Response Cohort Analysis Cohort: A Case-Control Study 37
Viral suppression in adults, adolescents and children receiving antiretroviral therapy in Cameroon: Adolescents at high risk of virological failure in the era of "test and treat" 36
COVID-19 considerations and strategy for a safe return to international football competitions: an African perspective 34
Predictive Efficacy of Dual Therapies Combining Integrase Strand Transfer Inhibitors with Second-Generation Non-Nucleoside Reverse Transcriptase Inhibitors Following HIV-1 Treatment Failure in Cameroon: Implications for the Use of a Long-Acting Therapeutic Strategy in Low- and Middle-Income Countries 34
Human immunodeficiency virus is a driven factor of human papilloma virus among women: Evidence from a cross-sectional analysis in Yaoundé, Cameroon 34
Empowering adolescents living with perinatally-acquired HIV: tailored CD4+ count assessment for optimized care, the EDCTP READY-study 33
Global burden of SARS-CoV-2 infection, hospitalization and case fatality rate among COVID-19 vaccinated individuals and its associated factors: A systematic review and meta-analysis protocol 33
Covid-19 pandemic related research in africa: Bibliometric analysis of scholarly output, collaborations and scientific leadership 32
Dolutegravir-Based Regimen Ensures High Virological Success despite Prior Exposure to Efavirenz-Based First-LINE ART in Cameroon: An Evidence of a Successful Transition Model 32
Evaluation of HIV-1 integrase variability by combining computational and probabilistic approaches 32
Thrombocytopenia according to antiretroviral drug combinations, viremia and CD4 lymphocytes among HIV-infected patients in Cameroon: A snapshot from the City of Yaoundé 32
COVID-19 preventive social-behavioural practices and exposure to SARS-CoV-2 among residents in the city of Yaounde: Lessons from the early phase of the pandemic in Cameroon 32
Human papillomavirus positivity and cervical lesions in relation to HIV infection: a comparative assessment in the Cameroonian female population 31
Current knowledge of human Mpox viral infection among healthcare workers in Cameroon calls for capacity-strengthening for pandemic preparedness 29
Achieving the Global Agenda toward HIV Cure Calls for Establishing a Research-for-Cure Academy in West and Central Africa 29
Epidemiological, virological and clinical features of SARS-CoV-2 among individuals during the first wave in Cameroon: Baseline analysis for the EDCTP PERFECT-Study RIA2020EF-3000 28
Challenges faced by the HIV testing system in low- and middle-income countries 28
HIV-1 integrase resistance associated mutations and the use of dolutegravir in Sub-Saharan Africa: A systematic review and meta-analysis 28
High concordance in SARS-CoV-2 detection between automated (Abbott m2000) and manual (DaAn gene) RT-PCR systems: The EDCTP PERFECT-Study in Cameroon 27
Evaluation of archived drug resistance mutations in HIV-1 DNA among vertically infected adolescents under antiretroviral treatment in Cameroon: Findings during the COVID-19 pandemic 27
Predictors of Virological Failure among People Living with HIV Switching from an Effective First-Line Antiretroviral Regimen 27
Evaluation of Circulating and Archived HIV-1 Integrase Drug-Resistance Variants among Patients on Third-Line ART in Cameroon: Implications for Dolutegravir-Containing Regimens in Resource-Limited Settings 26
Characterization of oral candidiasis according to antiretroviral treatment status, immunological and virological profiles among HIV infected patients in two health facilities in Yaoundé Cameroon: a crosssectional and analytical study 26
Physical Activity for Health Promotion and Disease Prevention in Africa and Cameroon: A Call to Action 24
Effectiveness of community-based peer facilitated psychological and social support interventions on improving mental health in Cameroonian adolescents with perinatal HIV: the IAS-CIPHER-2021/1214-ATE SMAVI controlled randomized trial (November 2021-May 2023) 20
Totale 2.398
Categoria #
all - tutte 8.255
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.255


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025496 9 0 46 14 5 3 86 60 31 12 109 121
2025/20261.822 76 9 134 100 127 99 177 67 291 199 239 304
2026/202780 73 7 0 0 0 0 0 0 0 0 0 0
Totale 2.398